PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth

Atherosclerosis
C A McMahanPathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group

Abstract

A risk score formula to estimate the probability of advanced atherosclerosis using coronary heart disease (CHD) risk factors was developed for persons 15-34 years of age by the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. We applied the PDAY risk score to autopsied individuals from the Community Pathology Study (CPS), a different population that included middle-aged as well as young subjects. The PDAY risk score was associated with extent of raised lesions in the coronary arteries of CPS cases 15-34 years of age. The PDAY risk score computed from only the modifiable risk factors was associated with extent of raised lesions in the coronary arteries of subjects 35-54 years of age. The association of the PDAY risk score with lesions in 15-34 year old CPS subjects validates the PDAY risk score. The associations in both younger (15-34 years) and older (35-54 years) subjects suggest a seamless progression of the effects of the modifiable risk factors on atherosclerosis from 15 to 54 years of age. These results support the proposal that early control of risk factors is likely to prevent or delay the onset of CHD.

References

Feb 18, 1971·The New England Journal of Medicine·L A TrivelliH T Lai
Jan 1, 1983·Journal of Chronic Diseases·L S WebberG S Berenson
May 29, 1998·Circulation·P W WilsonW B Kannel
Jun 12, 2002·Circulation·Henry C McGillUNKNOWN Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Shengxu LiGerald S Berenson
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Olli T RaitakariJorma S A Viikari
Apr 27, 2005·Archives of Internal Medicine·C Alex McMahanHenry C McGill

❮ Previous
Next ❯

Citations

Nov 3, 2010·The Journal of Clinical Investigation·Jonathan E FeigEdward A Fisher
Aug 20, 2010·Diabetology & Metabolic Syndrome·Alfredo HalpernMarcia Nery
Jan 11, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Brandon M Nathan, Antoinette Moran
Dec 3, 2010·Journal of Clinical Lipidology·W Virgil BrownPeter O Kwiterovich
Sep 22, 2009·American Journal of Preventive Medicine·Michael D SchmidtAlison J Venn
Jun 19, 2009·American Journal of Preventive Medicine·Yasmin A AltwaijriDarwin R Labarthe
Sep 10, 2014·Pediatric Annals·Michael Freemark
Oct 14, 2008·The Journal of Pediatrics·David M MaahsGeorgeanna J Klingensmith
Jun 1, 2008·Journal of Clinical Lipidology·C Alex McMahanHenry C McGill
Feb 22, 2008·Atherosclerosis·Lewis H KullerYuefang Chang
Apr 1, 2008·Journal of Clinical Lipidology·Courtney M Smalley, Stanley J Goldberg
Nov 9, 2010·Pediatric Diabetes·Nicole S GlaserUNKNOWN Lawson Wilkins Pediatric Endocrine Society Committee on Drugs and Therapeutics
May 13, 2014·Journal of the American College of Cardiology·Jennifer G Robinson, Samuel S Gidding
May 12, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·A Moráis LópezUNKNOWN Comité de Nutrición de la AEP
Jul 22, 2011·European Journal of Preventive Cardiology·Lars E LaugsandImre Janszky
Aug 6, 2008·Circulation·Daniel SteinbergJoseph L Witztum
Oct 24, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Godfrey S Getz, Catherine A Reardon
Dec 28, 2012·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Ye JinJun Jiang
Nov 17, 2019·Progress in Cardiovascular Diseases·Neil J Stone, Scott M Grundy
Jan 11, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.